Back to today’s briefing

Story perspectives

New Drug Combo Cuts LDL Cholesterol by 48.6%!

5/8/2025

42 9

Summary

Story summary

A groundbreaking clinical trial in Glasgow revealed that a new drug combination, obicetrapib and ezetimibe, significantly lowered LDL cholesterol by 48.6% in 407 patients after just 84 days. This promising therapy offers hope for high-risk individuals striving for better cholesterol management and a reduced risk of heart disease.

1 of 1

Story summary

A groundbreaking clinical trial in Glasgow revealed that a new drug combination, obicetrapib and ezetimibe, significantly lowered LDL cholesterol by 48.6% in 407 patients after just 84 days. This promising therapy offers hope for high-risk individuals striving for better cholesterol management and a reduced risk of heart disease.